NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Tydes? Mail in a sample (US only) and let us test it.

Test my supply
71%
Finnrick rating
#207 of 345 ranked vendors
33 of 41 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Tydes' purity-focused record is strongest on Tirzepatide, Retatrutide, and Semaglutide, where identity and most high-purity results clear despite recurring overfill caveats. Results are dispersed rather than uniform: BPC-157 and Ipamorelin are weak spots, batch IDs are generally absent, and recent lift appears driven by smoothing more than fresh clean lab.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tydes

We investigated who actually operates Tydes — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

25 pages5 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$9.50
82%
10
2
Retatrutide
$10.50
81%
9
3
Semaglutide
$11.00
77%
9
4
Mazdutide
$17.50
72%
3
5
Ipamorelin
$6.50
66%
1
6
Melanotan II
$4.50
64%
4
7
BPC-157
$6.00
48%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%17 Dec 2024: 93%17 Dec 2024: 92%17 Dec 2024: 73%23 Jan 2025: 62%23 Jan 2025: 63%27 Feb 2025: 63%27 Feb 2025: 63%27 Feb 2025: 63%27 Feb 2025: 66%27 Feb 2025: 61%27 Feb 2025: 61%27 Feb 2025: 62%28 Feb 2025: 62%28 Feb 2025: 62%28 Feb 2025: 61%28 Feb 2025: 61%28 Feb 2025: 61%28 Feb 2025: 62%2 Mar 2025: 69%2 Mar 2025: 70%3 Mar 2025: 69%5 Mar 2025: 66%20 Mar 2025: 65%20 Mar 2025: 65%20 Mar 2025: 64%20 Mar 2025: 64%20 Mar 2025: 65%20 Mar 2025: 65%25 Apr 2025: 68%25 Apr 2025: 66%25 Apr 2025: 65%25 Apr 2025: 64%30 Apr 2025: 64%30 Apr 2025: 64%30 Apr 2025: 64%30 Apr 2025: 65%30 Apr 2025: 66%30 Apr 2025: 66%30 Apr 2025: 66%30 Apr 2025: 67%18 Sept 2026: current 71%93%71%Dec 24Sep 26
Free peptide testing

Ordered peptides from Tydes? Mail in a sample (US only) and let us test it.

Test my supply
Tydes test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
30 Apr 2025
Pass
Mazdutide
lab nameView COA
30 Apr 2025
Pass
Tirzepatide
lab nameView COA
30 Apr 2025
Pass
Retatrutide
lab nameView COA
30 Apr 2025
Pass
Semaglutide
lab nameView COA
30 Apr 2025
Pass
Mazdutide
lab nameView COA
30 Apr 2025
Pass
Retatrutide
lab nameView COA
30 Apr 2025
Pass
Semaglutide
lab nameView COA
30 Apr 2025
Pass
Tirzepatide
lab nameView COA
25 Apr 2025
Fail
Tirzepatide
lab nameView COA
25 Apr 2025
Fail
Semaglutide
lab nameView COA
1-10 of 41

About Tydes test results from Finnrick

Tydes is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 41 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tydes peptides in this dataset are BPC-157 (5 tests), Ipamorelin (1 test) and Mazdutide (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 41 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Tydes? Mail in a sample (US only) and let us test it.

Test my supply